Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” About ARCT-2304 ARCT-2304 is a sa-mRNA vaccine candidate formulated within ...

Hawaii is the only US state that hasn't reported H5N1 avian flu in birds or animals. The state hasn't reported any recent ...

“Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR self-amplifying mRNA ... potential vaccine to protect ...

France raises bird flu risk to high as EU cases increase ... by approving Moderna's RSV vaccine for adults aged 60 and over, ...

Recent health news highlights include Recordati's nonchalance towards potential U.S. tariffs, Canada's approval of Moderna's ...

Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsEdward Berg - Senior Vice President and ...

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian ...

H5N1 Virus Isolated from Infected Dairy Worker Is 100% Lethal in Ferrets, but Does Not Appear to Be Circulating in Nature Anymore Oct. 28, 2024 — A strain of H5N1 avian influenza virus found in ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...